Prognostic significance of a combination of novel biomarkers in the long-term stratification of adverse outcomes in patients with ST-segment elevation myocardial infarction

Prognostic significance of a combination of novel biomarkers in the long-term stratification of adverse outcomes in patients with ST-segment elevation myocardial infarction

A multi-marker approach for assessing the prognosis of patients with ST-segment elevation myocardial infarction (STEMI) is a promising strategy.Aim. To assess the potential prognostic power of soluble growth stimulation gene-2 (sST2), pentraxin 3 (PTX3), and N-terminal pro-brain natriuretic peptide...

Full description

Bibliographic Details
Main Authors: D. F. Gareeva, A. F. Khamitova, I. A. Lakman, R. P. Ronzhin, R. Kh. Zulkarneev, M. R. Plotnikova, E. L. Tulbaev, L. J. Motloch, N. Sh. Zagidullin
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2020-12-01
Series:Российский кардиологический журнал
Subjects:
stemi
cardiovascular events
cardiovascular death
risk stratification
sst2
nt-probnp
pentraxin-3
Online Access:https://russjcardiol.elpub.ru/jour/article/view/3948

Internet

https://russjcardiol.elpub.ru/jour/article/view/3948

Similar Items